Efficacy and safety of tepotinib in Asian patients with advanced NSCLC with MET exon 14 skipping enrolled in VISION.
Terufumi KatoJames Chih-Hsin YangMyung-Ju AhnHiroshi SakaiMasahiro MoriseYuh-Min ChenJi-Youn HanJin-Ji YangJun ZhaoTe-Chun HsiaKarin BerghoffRolf BrunsHelene VioixSimone LangAndreas JohneXiuning LePaul K PaikPublished in: British journal of cancer (2024)
NCT02864992.